of control, IgG or anti-MRP-14 antibody (B). Mean fluorescence quantification per field is shown adjacent to images, scale 20µm, nuclei is counterstained with DAPI (blue). n=3, *P < 0.05. Online Table 1 No Event P (n=34) (n=34) Age, years +/- SD 69.6 (11.2) 74.0 (10.6) 0.10 Female (%) 9 (26.5%) 15 (44.1%) 0.13 Race 0.28 White 23 (67.7%) 17 (50%) 7 (20.6%) 8 (23.5%) Asian 0 (0%) 3 (8.8%) Other 4 (11.8%) 6 (17.7%) Ethnicity 0.73 Hispanic (%) 4 (12.1%) 6 (17.7%) Smoker 0.14 Current 6 (17.7%) 4 (11.8%) Former 23 (67.7%) 18 (52.9%) Never 5 (14.7%) 12 (35.3%) Diabetes (%) 16 (47.1%) 20 (58.8%) 0.33 0.43 Hypertension (%) 32(94.12%) 29(85.3%) Hyperlipidemia (%) 27(79.41%) 21 (61.8%) 0.11 Coronary artery disease 18(52.94%) 19 (55.9%) (%) 0.81 MRP 14, mean (SD) 247 (62.4) 303.1 (113.6) (ng/mL) 0.01
of control, IgG or anti-MRP-14 antibody (B). Mean fluorescence quantification per field is shown adjacent to images, scale 20µm, nuclei is counterstained with DAPI (blue). n=3, *P < 0.05. Online Table 1 No Event P (n=34) (n=34) Age, years +/- SD 69.6 (11.2) 74.0 (10.6) 0.10 Female (%) 9 (26.5%) 15 (44.1%) 0.13 Race 0.28 White 23 (67.7%) 17 (50%) 7 (20.6%) 8 (23.5%) Asian 0 (0%) 3 (8.8%) Other 4 (11.8%) 6 (17.7%) Ethnicity Hispanic (%) 4 (12.1%) 6 (17.7%) 0.73 Smoker 0.14 Current 6 (17.7%) 4 (11.8%) Former 23 (67.7%) 18 (52.9%) Never 5 (14.7%) 12 (35.3%) Diabetes (%) 16 (47.1%) 20 (58.8%) 0.33 Hypertension (%) 32(94.12%) 29(85.3%) 0.43 Hyperlipidemia (%) 27(79.41%) 21 (61.8%) 0.11 Coronary artery disease (%) 18(52.94%) 19 (55.9%) 0.81 MRP 14, mean (SD) (ng/mL) 247 (62.4) 303.1 (113.6) 0.01
1-s2.0-S0735109717414392-mmc1.docx